The Effects of modified-release fampridine on upper limb impairment in multiple sclerosis

被引：0
|
作者：
Simpson, M. [1 ]
Churilov, L. [2 ]
Bardsley, B. [1 ]
Heriot, E. [1 ]
Dimovitis, J. [1 ]
Carey, L. [3 ]
Macdonell, R. [1 ]
机构：
[1] Univ Melbourne, Austin Hlth, Melbourne, Vic, Australia
[2] Univ Melbourne, Stat, Melbourne, Vic, Australia
[3] Univ Melbourne, Melbourne, Vic, Australia
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1294
引用
收藏
页码：685 / 685
页数：1
相关论文
共 50 条
  • [1] Effects of modified-release fampridine on upper limb impairment in patients with Multiple Sclerosis
    Marion, Simpson
    Leonid, Churilov
    Belinda, Bardsley
    Joanne, Dimovitis
    Elise, Heriot
    Leeanne, Carey
    Richard, Macdonell
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 40
  • [2] Fampridine in multiple sclerosis patients: activity on upper limb function evaluated by kinematic analysis
    Solaro, C.
    Trabucco, E.
    Cella, M.
    Proietti, C.
    Casadio, M.
    Tanganelli, P.
    Sanguineti, V.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 588 - 589
  • [3] Efficacy of fampridine modified-release on ambulation in neuromyelitis optica: a pilot study
    Mutch, K. P.
    Wilson, M.
    Manohar, R.
    Zhao, S.
    Leggett, H.
    Hamid, S.
    Elsone, L.
    Jacob, A.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 612 - 613
  • [4] Sustained-release fampridine for multiple sclerosis
    Bever, Christopher T., Jr.
    Judge, Susan I. V.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (07) : 1013 - 1024
  • [5] Sustained-release fampridine in Multiple Sclerosis
    Hadavi, S.
    Baker, M. D.
    Dobson, R.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2014, 3 (01) : 17 - 21
  • [6] Subtle upper limb impairment in asymptomatic multiple sclerosis subjects
    Solaro, C.
    Brichetto, G.
    Casodio, M.
    Roccotagliata, L.
    Ruggiu, P.
    Mancardi, G. L.
    Morasso, P. G.
    Tanganelli, P.
    Sanguineti, V.
    MULTIPLE SCLEROSIS, 2007, 13 (03): : 428 - 432
  • [7] Upper limb function impairment in primary progressive multiple sclerosis
    Gottschalk, F.
    Muros-Le Rouzic, E.
    Vaskantiras, V.
    van Beek, J.
    Craveiro, L.
    Maywald, U.
    Wilke, T.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 199 - 200
  • [8] Sustained release oral fampridine in the treatment of multiple sclerosis
    Kachuck, Norman J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (12) : 2025 - 2035
  • [9] A guide to treating gait impairment with prolonged-release fampridine (Fampyra®) in patients with multiple sclerosis
    Ramio-Torrenta, L.
    Alvarez-Cermeno, J. C.
    Arroyo, R.
    Casanova-Estruch, B.
    Fernandez, O.
    Garcia-Merino, J. A.
    Hernandez, M. A.
    Izquierdo, G.
    Martinez-Yelamos, S.
    Meca, J.
    Moral, E.
    Olascoaga, J.
    Prieto, J. M.
    Saiz, A.
    NEUROLOGIA, 2018, 33 (05): : 327 - 337
  • [10] Effects of prolonged-release fampridine on postural control in patients with multiple sclerosis
    Reuter, K.
    Koeszeghi, L.
    Weller, D.
    Sutter, T.
    Kapitza, S.
    Farkas, M.
    Filli, L.
    Linnebank, M.
    Zoerner, B.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 521 - 521
12345